share_log

MoneyLion Analyst Ratings

Benzinga ·  Jul 27, 2023 05:19
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/27/2023 75% B. Riley Securities → $21 Initiates Coverage On → Buy
05/10/2023 108.33% Craig-Hallum $90 → $25 Maintains Buy
05/10/2023 150% Cantor Fitzgerald $3 → $30 Maintains Overweight
06/27/2022 -58.33% Loop Capital → $5 Initiates Coverage On → Buy
11/22/2021 -33.33% Cantor Fitzgerald → $8 Initiates Coverage On → Overweight
11/08/2021 -16.67% Craig-Hallum → $10 Initiates Coverage On → Buy
10/01/2021 0% Rosenblatt → $12 Initiates Coverage On → Buy

What is the target price for MoneyLion (ML)?

The latest price target for MoneyLion (NYSE: ML) was reported by B. Riley Securities on July 27, 2023. The analyst firm set a price target for $21.00 expecting ML to rise to within 12 months (a possible 75.00% upside). 3 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for MoneyLion (ML)?

The latest analyst rating for MoneyLion (NYSE: ML) was provided by B. Riley Securities, and MoneyLion initiated their buy rating.

When is the next analyst rating going to be posted or updated for MoneyLion (ML)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MoneyLion, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MoneyLion was filed on July 27, 2023 so you should expect the next rating to be made available sometime around July 27, 2024.

Is the Analyst Rating MoneyLion (ML) correct?

While ratings are subjective and will change, the latest MoneyLion (ML) rating was a initiated with a price target of $0.00 to $21.00. The current price MoneyLion (ML) is trading at is $12.00, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment